4 directorsName hiddenVisible after signing in and 3 others
Owners3 names in the annual accounts
50%Name after signing inVisible after signing in and 2 others
Documentsfilings and deeds
23-07-20268 days before the deadline
2025abbreviated format
Gross margin from -€1.2m to -€1.3mLoss of €1.7mStaff from 1.9 FTE to 3.3 FTECapital increase of €1,407,093.45 to €5,578,800.6828-111 director appointed, 1 resignation04-09Capital increase15-04
Lower net result than 95% of companies in wholesale trade. Sector median €38,102 · 10,749 companies.
Turnover not published in the abbreviated format
Checked score
Checked score
The higher the Checked score (0 to 100), the smaller the chance that the company goes bankrupt within twelve months. That chance sets the band, from Critical to Excellent, and within the band how the company does against its sector peers counts too. With a low score, agree a shorter payment term, an advance or security.
XXVisible after signing in
HiddenVisible after signing in
Bankruptcy probability within 12 months
Bankruptcy probability
It is the chance that the company goes bankrupt within twelve months, estimated from the registers, the annual accounts and the Belgian Official Gazette. At 0.2%, about 2 in 1,000 comparable companies go bankrupt. The higher it is, the shorter the payment term to agree.
XXVisible after signing in
Financial strength
Financial strength
Financial strength measures the balance sheet and the results with three figures out of 100 from the latest annual accounts: solvency, liquidity and profitability. It does not directly set the Checked score's band. How the company does against its sector peers on these and on growth does count for its place within the band.
XXVisible after signing in
XXVisible after signing in
XXVisible after signing in
Score breakdown
Visible after signing inVisible after signing in
Comparable companies, two years later
In July 2024, 1,134 companies had the same profile as FIDELMED has now. Each dot stands for 3 companies, two years later.
86.3%
were still trading
6.7%
stopped another way
6.4%
went bankrupt
Micro
5 to 10 years old
solvency 10 to 30%
a loss of 10% of the balance sheet or more
Another 0.5% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
The companies in ten equal groups, from the lowest to the highest expected share
Group
Expected
Actual
1
0.2%
0.2%
2
0.3%
0.5%
3
0.5%
0.6%
4
0.7%
0.8%
5
0.9%
0.9%
6
1.3%
1.5%
7
1.6%
1.8%
8
1.8%
1.8%
9
2.9%
3.1%
10
5.6%
6.1%
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 1,134 companies, not a prediction for FIDELMED. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit verdict
The credit verdict says how much credit you can give the company on open account. “Acceptable” means normal terms, “With conditions” means limiting the amount or the term. “Not advised” means asking for payment up front.
Visible after signing inVisible after signing in
Credit check for an amount and term of your choice
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Signal hidden, visible after signing inVisible after signing in
Hidden signalVisible after signing in
Signal visible after signing inVisible after signing in
Signal hidden, visible after signing inVisible after signing in
Hidden signalVisible after signing in
Board and ownership
Name after signing inVisible after signing in
Director, Name hiddenVisible after signing in, since 27-06-2018
Hidden nameVisible after signing in
Director, Name after signing inVisible after signing in, since 27-06-2018
Name hiddenVisible after signing in
Director, Hidden nameVisible after signing in
Name after signing inVisible after signing in
Director, Name hiddenVisible after signing in, since 17-04-2025
Hidden nameVisible after signing in 24.41%equity €5.4m (2026) · annual accounts 31-03-2026 of Name after signing inVisible after signing in
Name hiddenVisible after signing in 0.94%equity €1.0m (2025) · annual accounts 30-09-2025 of Hidden nameVisible after signing in
Name after signing inVisible after signing inscore XXVisible after signing inequity €290,692 (2025) · annual accounts 2025 of Hidden nameVisible after signing in
3 directors reappointedHidden nameVisible after signing in, Name after signing inVisible after signing in and Name hiddenVisible after signing in · General meeting of 24-06-2026 · Gazette deed
Capital increase of €1,407,093.45 to €5,578,800.68
The capital rose from €4,171,707.23 to €5,578,800.68, with 4,215 new shares · General meeting of 29-10-2025 · Gazette deed
1 director appointed, 1 resignationHidden nameVisible after signing in resigns · Name after signing inVisible after signing in and Name hiddenVisible after signing in act as permanent representatives · Hidden nameVisible after signing in appointed · General meeting of 08-07-2025 · Gazette deed
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0698912120
Sector peers are the companies with the same activity (NACE code) and, where stated, the same size, that the company is compared with. A percentile says how many of them do worse.
These companies have the same main activity as FIDELMED: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €1.1m and €4.5m, founded between 2011 and 2020.